• SvenskaSvenska
Active Biotech
  • Home
  • About
    • Active Biotech in Brief
    • Board of Directors
    • Management
    • Business Concept
    • Corporate Governance
      • Corporate Governance Report 2019
      • Article of Association
      • Audit committee
      • Scientific committee
      • Election Committee
      • General Meetings
      • Auditors
    • Partnerships
    • Career
  • Projects
    • Project Overview
    • Naptumomab
    • Tasquinimod
    • Laquinimod
    • Patents
    • Orphan Drug Designation
  • Investor
    • Investor
    • Analyst coverage
    • Financial Calendar
    • Financial Reports
      • Interim Reports
      • Annual Reports
    • Stock
    • Ownership
    • Official Documents
      • Rights Issue 2014
      • Rights Issue 2016
      • Rights Issue 2018
      • Rights Issue 2021
  • Media
    • Press Contact
    • Press Releases
      • Subscribe
    • News
    • Company Presentation
    • Image Bank
  • Contact
Copyright © 2021 Active Biotech AB. All Rights Reserved.
Design by Clavis Communications.

Financial Calendar

May 19, 2021, Annual General Meeting

November 12, 2020

November 4, 2021, Interim report

November 12, 2020

August 5, 2021, Interim report

November 12, 2020

April 22, 2021, Interim report

November 12, 2020

May 19, 2020, Annual General Meeting

December 9, 2019

More info

February 11, 2021, Year-end report 2020

December 9, 2019

November 5, 2020, Interim report

December 9, 2019

August 6, 2020, Interim report

December 9, 2019

April 23, 2020, Interim report

December 9, 2019

April 4, 2019, Extraordinary shareholders’ meeting

March 13, 2019

More info

February 6, 2020, Year-end report 2019

November 27, 2018

November 14, 2019, Interim report

November 27, 2018

August 8, 2019, Interim report

November 27, 2018

May 23, 2019, Annual General Meeting

November 27, 2018

April 25, 2019, Interim report

November 27, 2018

February 14, 2019, Year-end report 2018

March 8, 2018

November 15, 2018, Interim report

March 8, 2018

August 9, 2018, Interim report

March 8, 2018

Annual General Meeting 2018

March 8, 2018
Read all information about the 2018 Annual General Meeting here.

Interim report

March 8, 2018

Extraordinary shareholders’ meeting

March 8, 2018

Content

  • Home
  • About
  • Projects
  • Investor
  • Media
  • Contact

Postal Address

Active Biotech AB
P.O. Box 724
SE-220 07 Lund
Sweden

Visiting Address

Active Biotech AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

+46 46 19 20 00
info@activebiotech.com

LinkedIn

Copyright © 2021 Active Biotech AB. All Rights Reserved.
Design by Clavis Communications.
This site uses cookies.